The Methicillin-resistant Staphylococcus aureus (MRSA) strains cause wide spectrum infections in hospitals and are responsible for the majority of the communityacquired infections. The emergence of community-acquired MRSA in patients without risk factors represents a high risk for public health.
Introduction
taphylococcus aureus, as an important cause of community-acquired and nosocomial infections, has remained a significant health problem across the world (1) (2) (3) (4) . Methicillinresistant Staphylococcus aureus (MRSA) was first recognized in the early 1960s, shortly after the introduction of methicillin, a narrow spectrum semi-synthetic penicillin in clinical practice, through the acquisition of the mecA gene. This gene encodes for a modified form of penicillin-binding protein, which has a lower affinity for all beta-lactam antibiotics (3) (4) (5) . The MRSA strains are responsible for a wide spectrum of clinical diseases, ranging from superficial infection of the skin and soft tissue to severe and life-threatening diseases such as pneumonia, sepsis, osteomyelitis, endocarditis, and toxic shock syndrome (1, 2) . After the emergence of MRSA in the clinical practice, in the late 1980s, vancomycin became the first choice for treatment of MRSA infections in the world. Shortly after that, S. aureus isolates with reduced susceptibility to teicoplanin, a structural relative of vancomycin, were reported in Europe in 1990. Subsequently, the emergence of Vancomycin-intermediate resistant (VISA) and Vancomycin-resistant S. aureus (VRSA) isolates were reported in 1997 and 2002, respectively. Since then, the increased rate of VRSA was reported from all over the world. The option for treatment of MRSA-induced infections and clinical symptoms are limited. Therefore, MRSA has remained a significant threat to human health globally (6) (7) (8) (9) (10) (11) (12) .
Molecular typing of MRSA is an essential tool in the surveillance of healthcare-associated infections. Rapid identification of the strains will help control and prevention of MRSA, causing community-acquired or nosocomial infections. There are several molecular techniques for MRSA typing such as Multilocus Sequence Typing (MLST), Pulsedfield Gel Electrophoresis (PFGE), Staphylococcal Cassette Chromosome mec (SCCmec) typing and Staphylococcal Protein A (spa) typing (1) . These methods are accurate and time-consuming. Thus, due to laborious character and difficulties in comparing data between laboratories and the requirement for inter-laboratory standardization, spa typing method, which is based on assessment of short sequence repeats of hypervariable X region in the spa gene, exhibits excellent discriminatory power and has become a useful typing tool, with cheaper procedure, and standardized nomenclature (7) . Furthermore, spa typing allows data comparison between clinical laboratories at the international and na-tional levels (13, 14) . The prevalence of different spa types among S. aureus isolates varies in different areas around the world (9) . Although several studies have reported the spa typing and characterization of MRSA in patients in healthcare settings, this subject has not been investigated in healthy children in the North of Iran. The present study aimed at molecular typing via spa typing and characterization of nasal carriage methicillin-resistant Staphylococcus aureus isolates from healthy children living in the North of Iran.
Methods

Isolation and identification of Methicillin-resistant S. aureus, vancomycin-intermediate resistant, and vancomycin-resistant S. aureus strains
In this descriptive study, 26 non-duplicate MRSA isolates were recovered from healthy children aged 6-12 years living in the North of Iran. These isolates were identified as S. aureus methicillin-resistant, as we described previously (4) . Identification of these isolates was performed according to the standard microbiological procedures (morphology, Gram stain, catalase test, coagulase test, mannitol salt agar fermentation, and molecular procedures). Antibiotic susceptibility test was performed by the Kirby-Bauer method according to the Clinical and Laboratory Standards Institute (CLSI) guideline and antibiotic disks, including cefoxitin, cefalotin, clindamycin, cefazolin, co-amoxiclav, co-trimoxazole, and cephalexin (15) .
For detection of MRSA strains, oxacillin screen agar was used. Staphylococcus strains were cultured on Muller Hinton agar containing 4% NaCl, and six mg/L oxacillin and then incubated for 24 hours (4, 12). Genomic DNA was extracted by the boiling method. Then for confirmation of MRSA strains, the isolates were subjected to Multiplex PCR assay to detect spa and mecA genes, and the previously described protocol was adjusted (4). For detection of VISA and VRSA isolates, the minimum inhibitory concentration of vancomycin by microdilution broth method according to CLSI standards was performed. VISA was defined when S. aureus strains exhibited increased resistance to vancomycin (MIC =4-8µg/ mL), and VRSA as S. aureus isolates showed complete resistance to vancomycin (MIC ≥16µg/mL) (15, 16) .
The spa typing of MRSA strains
Spa type is a repeated sequence comprising 24 repeated nucleotides (eight codons). To do typing, the short Sequence Repeats (SSR) of the polymorphic X S region of the protein A gene (spa) from MRSA isolates were amplified with the following primers: spa-1113F 5' -TAAAGACGATCCTTCGGTGAGC -3' and spa-1514R 5' -C AGCAGTAGTGCCGTTTGCTT -3'. PCR reactions were performed in 25μL final volumes containing 2μL of purified DNA, 0.5μL of each primer, 12.5μL of 2 x Green PCR Master Mix and 8.5μL of distilled water. The PCR amplification conditions for spa primer were as follows: the initial denaturation at 94°C for five minutes, and next 30 cycles consisting of a denaturation step at 94°C for 30 seconds, annealing at 59°C for one minute, extension at 72°C for one minute, as well as a final extension step at 72°C for ten minutes, and storage at 4°C at the end. S. aureus ATCC 25923 contains spa gene and considered as the positive control.
Amplified products were directly sequenced for both strands using the PCR primers by Bioneer Company (Seoul, South Korea). Sequences were then checked for the quality and trimmed by CLC Genomics version 12.0.2 (Qiagen, Germany). The spa typing was per-formed by the module implicated inside the BioNumerics software version 7.6.3 (Applied Maths, Belgium). The sequences were submitted to Genbank under the accession number MK443456-MK443471. Finally, the type ability of this study was calculated as 87.1% with the method described previously (17).
Results
A total of 26 healthy boys with the Mean±SD age of 8.84±3.36 year (age range: 6 to 12 year), nasal carrying MRSA, enrolled in this study. All MRSA strains isolated from these children contained the mecA gene. The rate of resistant isolates to cefoxitin, cefalotin, clindamycin, cefazolin, co-amoxiclav, co-trimoxazole, and cephalexin were 69.23%, 100%, 46.15%, 96.15%, 100%, 3.48%, and 100%, respectively. Table 1 presents the in vitro susceptibilities of vancomycin against MRSA isolates. Totally six (23.07%) and five (19.23%) isolates were VISA and VRSA, respectively. The typing of all isolates yielded 14 spa types as following: t790 (23.07%), t2962 (15.38%), t267 (15.38%), t159 (7.69%) and t701, t094, t1816, t11332, t937, t2135, t180, t160 (1 [3.84%] isolate per each type) ( Table 2 ). An interesting finding of this study was the emergence of two new spa types found with the Ridom Spa Server that was submitted in the server (www. spaserver.ridom.de).
Discussion
The MRSA strains produce various clinical manifestations in the hospitals and the community (18) (19) (20) (21) (22) . This pathogen can adapt to a variety of conditions, and successful clones can result in epidemic or pandemic infections (7) .
In this study, we characterized the MRSA strains isolated from the nose of healthy children. Although children have higher persistent carriage rates than adults, the rate of nasal carrying S. aureus varies depending on age, from approximately 45% during the first eight weeks to 21% by six months. Nevertheless, there is a transition from persistent carriage to intermittent or no carriage states during adolescence (18) . Generally , nasal carriers of MRSA have an increased risk of acquiring infection with this pathogen. In our study, we found five MRSA strains harbored mecA gene, which were also VRSA by the phenotypical method. Our findings are alarming for the presence of vancomycin-resistant MRSA strains among healthy children, which should be addressed in future studies with larger sample sizes. Many Iranian laboratories do not follow a specific guideline for reporting and confirming VRSA, so the prevalence of VRSA strains is not known in our country. Askari et al. in a systematic review reported 24 VRSA isolates from Iran up to September 2012 (11) .
Vancomycin is the primary antibiotic for the treatment of serious infections caused by MRSA strains. However, VRSA is defined as an isolate with a minimum inhibitory concentration of vancomycin greater than or equal to 16 μg/mL based on the determination by broth microdilution method and there are some reports regarding the genotype-negative phenotype-positive VRSA within resistance range (13, 16) . Further studies are needed to advance identification of VISA and VRSA isolates, which in turn can be used to assess better the prevalence of these isolates, as well as to facilitate the development of optimal treatments (16) . Although new therapies such as phage therapy have been suggested for the treatment of MRSA infection and this new therapeutic option has a promising future as an alternative or a supple-ment to antibiotic treatments of infection due to MRSA strains, antibiotic therapy is still the first choice (23) (24) (25) .
Nowadays, typing and analysis of MRSA strains have become a routine procedure in many countries and are being used as a tool to show the relationship between strains and clones. Although many MRSA genotypes and clonal clusters have been identified in different geographic regions, certain gene clones are predominant in some regions (26) (27) (28) (29) (30) . For example, in the current study and among 26 MRSA isolates, we found 14 different genotypes. Asadollahi et al. in a comprehensive review reported that The Netherlands has the most diverse range of spa types (34 types), followed by China (22 types), Germany (16 types), UK (15 types), Spain (11 types), Sweden (10 types), Iran (8 types), France (7 types), and Switzerland (6 types). In our study, we detected that the spa type t790 (in six isolates) was predominant, and t2962 (in four isolates), t267 (in four isolates), t159 (in two isolates) and t701, t094, t1816, t11332, t937, t2135, t180, t160 (in one isolate) were in the next lines.
Asadollahi et al. reported that the spa types t008 and t002 are the most frequently repeated spa types in 16 countries. The following most frequently repeated spa types were t037 (12 countries), t044 (11 countries), t084 (8 countries), t012 and t127 (7 countries), t041 (6 countries), and t019, t011, t034, t355, t189, t304 (5 countries) (7) . In Asia, t030 was the dominant type located in China, while in Iran, this type reported as the fifth most common spa type (7) .
Fourteen spa types among 26 MRSA strains of nasal carriage S. aureus are caused by different variants of the spa genes. Detection of the molecular characteristics of S. aureus isolates is important for distinguishing the relations between isolates, and consequently, the implementation of appropriate infection control measures. Conclusion of this study showed the different variants of MRSA strains among healthy Iranian children. Moreover, the characterized isolates with reduced sensitivity to vancomycin are of concern. Continuous surveillance studies to monitor MRSA strains and the health education in school should be encouraged to gain a better understanding of the circulating MRSA and to prevent community-spread of this pathogen.
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